MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.2300
+0.0145 (6.73%)
Jun 22, 2026, 5:31 PM CET

SWX:MMTX Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
0.64-
Cost of Revenue
0.05-
Gross Profit
0.59-
Selling, General & Admin
5.820
Research & Development
5.29-
Operating Expenses
11.110
Operating Income
-10.52-0
Interest Expense
-0.27-
Interest & Investment Income
0.310
Currency Exchange Gain (Loss)
0.58-
Other Non Operating Income (Expenses)
-0.02-
Pretax Income
-9.91-0
Net Income
-9.91-0
Net Income to Common
-9.91-0
Shares Outstanding (Basic)
2113
Shares Outstanding (Diluted)
2113
Shares Change (YoY)
64.65%-
EPS (Basic)
-0.48-0.00
EPS (Diluted)
-0.48-0.00
Free Cash Flow
-13.45-0
Free Cash Flow Per Share
-0.65-
Gross Margin
92.06%-
Operating Margin
-1637.85%-
Profit Margin
-1542.99%-
Free Cash Flow Margin
-2094.39%-
EBITDA
-9.14-
D&A For EBITDA
1.37-
EBIT
-10.52-0
Revenue as Reported
0.64-